Recall for Product Correction of Span-K®


HPS Pharmacies wish to advise that Aspen Pharmacare, in consultation with the Therapeutic Goods Administration (TGA), has given notice of a recall for product correction of:

Span-K® Tablets
Potassium chloride 600mg
ARTG 27978

This recall for product correction has been initiated as the bottles have been supplied without child-resistant caps. There is no concern relating to the quality or safety of the medication, other than the absence of child-resistant packaging.

Please inspect your stocks and quarantine all affected products for replacement of bottle tops with child-resistant caps. There is no need to return affected stock to your wholesaler or Aspen Pharmacare.

If HPS Pharmacies provide imprest management services to your facility, an HPS representative will inspect your stock and quarantine all affected products for correction. Your HPS Pharmacies Pharmacy Manager/Director of Pharmacy will contact your clinicians if there is an immediate impact to your facility.

Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies, or Aspen Pharmacare on 1300 659 646.

Information regarding expected dates for supply may vary subject to delays which are out of our control. HPS Pharmacies does not accept responsibility for such changes but will endeavour to keep our clients updated as information is made available from drug manufacturers or wholesalers.

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates